Margery Connelly, PhD, MBA

Connelly, Margery 2016

Dr. Connelly has over 20 years of experience in academia and the pharmaceutical industry. She currently works as Strategic Director, Translational Research at LabCorp (LipoScience). She has spent the last 3 years applying her scientific expertise toward the development and clinical validation of new NMR-based biomarkers for various disease indications, including cardiovascular disease, inflammation and metabolic disorders such as metabolic syndrome, diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and liver fibrosis.